1. Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B

   • Steven J. Crowley
   • David Tognarini
   • Michael Lees

   Original Research Article 21 September 2012 Pages: 409 - 427

   

2. Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide

   • Kevin T. Stroupe
   • Melissa M. Forthofer
   • Michael D. Murray

   Original Research Article 21 September 2012 Pages: 429 - 440

   

3. Decision Analytic Modelling in the Economic Evaluation of Health Technologies

   Consensus Conference Papers 21 September 2012 Pages: 443 - 444

4. Modelling in Health Economic Evaluation

   • Alan Brennan
   • Ron Akehurst

   Consensus Conference Papers 21 September 2012 Pages: 445 - 459

   

5. Assessing Quality in Decision Analytic Cost-Effectiveness Models

   • Mark Sculpher
   • Elisabeth Fenwick
   • Karl Claxton

   Consensus Conference Papers 21 September 2012 Pages: 461 - 477

   

6. Handling Uncertainty in Cost-Effectiveness Models

   • Andrew H. Briggs

   Consensus Conference Papers 21 September 2012 Pages: 479 - 500

   

7. Testing the Validity of Cost-Effectiveness Models

   • Chris McCabe
   • Simon Dixon

   Consensus Conference Papers 21 September 2012 Pages: 501 - 513

   

8. Mirtazapine

   • Kristin J. Holm
   • Blair Jarvis
   • Rachel H. Foster

   Adis Pharmacoeconomic Drug Evaluation 21 September 2012 Pages: 515 - 534